Clinical trial NCT00619177: Assessing the Impact of MOVALIS in Osteoarthritis and Rheumatoid Arthritis Patients on Health Related Quality of Life
Official title: Assessing the Impact of MOVALIS on Health Related Quality of Life
Study type: OBSERVATIONAL
Overall status: COMPLETED
Conditions: Osteoarthritis
Arthritis, Rheumatoid
Lead sponsor: Boehringer Ingelheim
Sponsor class: INDUSTRY
First posted: 2008-02-20
Enrollment: 3569
Sex: ALL
Minimum age (years): 18
Standard ages: ADULT
OLDER_ADULT
Accepts healthy volunteers: no
Observational model: COHORT
Time perspective: PROSPECTIVE
Sampling method: NON_PROBABILITY_SAMPLE
Study population: primary care and rheumatology clinics

Brief summary: The objective of the observational study is to examine the effect of MOVALIS (Meloxicam) therapy on Health Related Quality of Life (HRQoL) in the diverse region of Central and Eastern Europe. The Medical Outcomes Study 12 Item Short Form Health Survey version 2 (SF-12v2) will be used as the instrument to measure any change in physical wellbeing (Physical Component Summary, PCS) and mental wellbeing (Mental Component Summary, MCS) of patients following MOVALIS (Meloxicam) therapy.


Eligibility criteria: Inclusion Criteria (according to Summary of Product Characteristics (SPC) ):

1. Male or female patients aged 18 years or above 2 Females of child bearing age must be using adequate contraception (hormonal or barrier method of birth control) 3. Patients with symptoms of acute, painful osteoarthritis or rheumatoid arthritis 4. Patients requiring therapy with non-steroidal anti-inflammatory drugs (NSAIDs) 5. Patients requiring either parenteral and/or oral NSAIDs 6. Patients who have not taken another NSAID or Cyclo-oxygenase-2 (COX-2) inhibitor in the previous 7 days Pain intensity on the visual analogue scale (VAS) 25 mm and above

Exclusion Criteria (according to contraindications of Summary of Product Characteristics (SPC) ):

1. Known hypersensitivity to meloxicam or any excipient of the product, known or suspected hypersensitivity to analgesics, antipyretics or NSAIDs
2. Patients who have developed signs of asthma, nasal polyps, angio-oedema or urticaria following the administration of aspirin or other NSAIDs
3. Active peptic ulcer, gastrointestinal perforation or bleeding within the last 6 months
4. Severe liver failure
5. Non-dialysed severe renal failure
6. Pregnancy or breastfeeding
7. Haemostasis disorders or concomitant treatment with anticoagulants
8. Severe congestive heart failure

Primary outcomes:
measure: Mean Change in Medical Outcomes Study 12-item Short-Form Health Survey, Version 2 Score From Baseline to Final Visit.
timeFrame: baseline and final visit (approximately 4 weeks)
measure: Mean Change in SF 12 MCS Score From Baseline to Final Final Visit.Medical Outcomes Study 12-Item Short-Form Health Survey, Version 2
timeFrame: Baseline and final visit (approximately 4 weeks)
Secondary outcomes:
measure: Change From Baseline of Pain Intensity on Visual Analogue Scale
timeFrame: Approximately four weeks of treatment
measure: Patient Assessment of Efficacy
timeFrame: after approximately 4 weeks of treatment
measure: Physician Assessment of Efficacy
timeFrame: after approximately 4 weeks of treatment
Other outcomes:
Locations:
city: Split
country: Croatia
facility: Boehringer Ingelheim Investigational Site
city: Zagreb
country: Croatia
facility: Boehringer Ingelheim Investigational Site
city: As
country: Czech Republic
facility: Boehringer Ingelheim Investigational Site
city: Babice
country: Czech Republic
facility: Boehringer Ingelheim Investigational Site
city: Benesov nad Ploucnicí
country: Czech Republic
facility: Boehringer Ingelheim Investigational Site
city: Benesov u Prahy
country: Czech Republic
facility: Boehringer Ingelheim Investigational Site
city: Benesov
country: Czech Republic
facility: Boehringer Ingelheim Investigational Site
city: Benátky nad Jizerou
country: Czech Republic
facility: Boehringer Ingelheim Investigational Site
city: Beroun
country: Czech Republic
facility: Boehringer Ingelheim Investigational Site
city: Blansko
country: Czech Republic
facility: Boehringer Ingelheim Investigational Site
city: Blatnice pod svatým Antonínkem
country: Czech Republic
facility: Boehringer Ingelheim Investigational Site
city: Bohusovice nad Ohrí
country: Czech Republic
facility: Boehringer Ingelheim Investigational Site
city: Bolatice
country: Czech Republic
facility: Boehringer Ingelheim Investigational Site
city: Boskovice
country: Czech Republic
facility: Boehringer Ingelheim Investigational Site
city: Bratríkov
country: Czech Republic
facility: Boehringer Ingelheim Investigational Site
city: Breclav
country: Czech Republic
facility: Boehringer Ingelheim Investigational Site
city: Brno
country: Czech Republic
facility: Boehringer Ingelheim Investigational Site
city: Broumov
country: Czech Republic
facility: Boehringer Ingelheim Investigational Site
city: Bruntál
country: Czech Republic
facility: Boehringer Ingelheim Investigational Site
city: Buchlovice
country: Czech Republic
facility: Boehringer Ingelheim Investigational Site
city: Bysice
country: Czech Republic
facility: Boehringer Ingelheim Investigational Site
city: Bystrice nad Pernstejnem
country: Czech Republic
facility: Boehringer Ingelheim Investigational Site
city: Bílina
country: Czech Republic
facility: Boehringer Ingelheim Investigational Site
city: Bílovec
country: Czech Republic
facility: Boehringer Ingelheim Investigational Site
city: Bílovice nad Svitavou
country: Czech Republic
facility: Boehringer Ingelheim Investigational Site
city: Cernosice
country: Czech Republic
facility: Boehringer Ingelheim Investigational Site
city: Cernozice
country: Czech Republic
facility: Boehringer Ingelheim Investigational Site
city: Ceská Lípa
country: Czech Republic
facility: Boehringer Ingelheim Investigational Site
city: Ceská Trebová
country: Czech Republic
facility: Boehringer Ingelheim Investigational Site
city: Ceské Budojovice
country: Czech Republic
facility: Boehringer Ingelheim Investigational Site
city: Ceský Tesín
country: Czech Republic
facility: Boehringer Ingelheim Investigational Site
city: Cheb
country: Czech Republic
facility: Boehringer Ingelheim Investigational Site
city: Chodov
country: Czech Republic
facility: Boehringer Ingelheim Investigational Site
city: Chomutov
country: Czech Republic
facility: Boehringer Ingelheim Investigational Site
city: Chropyne
country: Czech Republic
facility: Boehringer Ingelheim Investigational Site
city: Chrudim
country: Czech Republic
facility: Boehringer Ingelheim Investigational Site
city: Cáslav
country: Czech Republic
facility: Boehringer Ingelheim Investigational Site
city: Decín
country: Czech Republic
facility: Boehringer Ingelheim Investigational Site
city: Dobrany
country: Czech Republic
facility: Boehringer Ingelheim Investigational Site
city: Dobruska
country: Czech Republic
facility: Boehringer Ingelheim Investigational Site
city: Dobrís
country: Czech Republic
facility: Boehringer Ingelheim Investigational Site
city: Dol . Lou.
country: Czech Republic
facility: Boehringer Ingelheim Investigational Site
city: Dolní Benesov
country: Czech Republic
facility: Boehringer Ingelheim Investigational Site
city: Dolní Berkovice
country: Czech Republic
facility: Boehringer Ingelheim Investigational Site
city: Domazlice
country: Czech Republic
facility: Boehringer Ingelheim Investigational Site
city: Drnovice
country: Czech Republic
facility: Boehringer Ingelheim Investigational Site
city: Dvur Králové nad Labem
country: Czech Republic
facility: Boehringer Ingelheim Investigational Site
city: Frenstát
country: Czech Republic
facility: Boehringer Ingelheim Investigational Site
city: Frýdek-Místek
country: Czech Republic
facility: Boehringer Ingelheim Investigational Site
city: Frýdlant
country: Czech Republic
facility: Boehringer Ingelheim Investigational Site
city: Fulnek
country: Czech Republic
facility: Boehringer Ingelheim Investigational Site
city: Hanusovice
country: Czech Republic
facility: Boehringer Ingelheim Investigational Site
city: Havlíckuv Brod
country: Czech Republic
facility: Boehringer Ingelheim Investigational Site
city: Havírov
country: Czech Republic
facility: Boehringer Ingelheim Investigational Site
city: Hermanuv Mestec
country: Czech Republic
facility: Boehringer Ingelheim Investigational Site
city: Hlucín
country: Czech Republic
facility: Boehringer Ingelheim Investigational Site
city: Hluk
country: Czech Republic
facility: Boehringer Ingelheim Investigational Site
city: Hodonice
country: Czech Republic
facility: Boehringer Ingelheim Investigational Site
city: Hodonín
country: Czech Republic
facility: Boehringer Ingelheim Investigational Site
city: Holesov
country: Czech Republic
facility: Boehringer Ingelheim Investigational Site
city: Holice
country: Czech Republic
facility: Boehringer Ingelheim Investigational Site
city: Horice v Podkrkonosí
country: Czech Republic
facility: Boehringer Ingelheim Investigational Site
city: Horní Berkovice
country: Czech Republic
facility: Boehringer Ingelheim Investigational Site
city: Horní Slavkov
country: Czech Republic
facility: Boehringer Ingelheim Investigational Site
city: Horovice
country: Czech Republic
facility: Boehringer Ingelheim Investigational Site
city: Hostinné
country: Czech Republic
facility: Boehringer Ingelheim Investigational Site
city: Hostka
country: Czech Republic
facility: Boehringer Ingelheim Investigational Site
city: Hradec Králové
country: Czech Republic
facility: Boehringer Ingelheim Investigational Site
city: Hronov
country: Czech Republic
facility: Boehringer Ingelheim Investigational Site
city: Hrusovany nad Jevisovkou
country: Czech Republic
facility: Boehringer Ingelheim Investigational Site
city: Hrádek n.N.
country: Czech Republic
facility: Boehringer Ingelheim Investigational Site
city: Hulín
country: Czech Republic
facility: Boehringer Ingelheim Investigational Site
city: Hustopece u Brna
country: Czech Republic
facility: Boehringer Ingelheim Investigational Site
city: Hustopece
country: Czech Republic
facility: Boehringer Ingelheim Investigational Site
city: Jablonec n.N.
country: Czech Republic
facility: Boehringer Ingelheim Investigational Site
city: Jablonec
country: Czech Republic
facility: Boehringer Ingelheim Investigational Site
city: Jablunkov
country: Czech Republic
facility: Boehringer Ingelheim Investigational Site
city: Jaromer
country: Czech Republic
facility: Boehringer Ingelheim Investigational Site
city: Javorník
country: Czech Republic
facility: Boehringer Ingelheim Investigational Site
city: Jeseník
country: Czech Republic
facility: Boehringer Ingelheim Investigational Site
city: Jicín
country: Czech Republic
facility: Boehringer Ingelheim Investigational Site
city: Jihlava
country: Czech Republic
facility: Boehringer Ingelheim Investigational Site
city: Jirkov
country: Czech Republic
facility: Boehringer Ingelheim Investigational Site
city: Kadan
country: Czech Republic
facility: Boehringer Ingelheim Investigational Site
city: Kaplice
country: Czech Republic
facility: Boehringer Ingelheim Investigational Site
city: Karlovy Vary
country: Czech Republic
facility: Boehringer Ingelheim Investigational Site
city: Karviná
country: Czech Republic
facility: Boehringer Ingelheim Investigational Site
city: Kladno
country: Czech Republic
facility: Boehringer Ingelheim Investigational Site
city: Klatovy
country: Czech Republic
facility: Boehringer Ingelheim Investigational Site
city: Klobouky
country: Czech Republic
facility: Boehringer Ingelheim Investigational Site
city: Klásterec n. Ohrí
country: Czech Republic
facility: Boehringer Ingelheim Investigational Site
city: Kolín
country: Czech Republic
facility: Boehringer Ingelheim Investigational Site
city: Konice
country: Czech Republic
facility: Boehringer Ingelheim Investigational Site
city: Koprivnice
country: Czech Republic
facility: Boehringer Ingelheim Investigational Site
city: Kosmonosy
country: Czech Republic
facility: Boehringer Ingelheim Investigational Site
city: Kostelec nad Orlicí
country: Czech Republic
facility: Boehringer Ingelheim Investigational Site
city: Kralupy nad Vltavou
country: Czech Republic
facility: Boehringer Ingelheim Investigational Site
city: Krnov
country: Czech Republic
facility: Boehringer Ingelheim Investigational Site
city: Kromeríz
country: Czech Republic
facility: Boehringer Ingelheim Investigational Site
city: Krouna
country: Czech Republic
facility: Boehringer Ingelheim Investigational Site
city: Krupka
country: Czech Republic
facility: Boehringer Ingelheim Investigational Site
city: Králuv Dvur
country: Czech Republic
facility: Boehringer Ingelheim Investigational Site
city: Kunovice
country: Czech Republic
facility: Boehringer Ingelheim Investigational Site
city: Kurim
country: Czech Republic
facility: Boehringer Ingelheim Investigational Site
city: Kyjov
country: Czech Republic
facility: Boehringer Ingelheim Investigational Site
city: Lanskroun
country: Czech Republic
facility: Boehringer Ingelheim Investigational Site
city: Ledec nad Sázavou
country: Czech Republic
facility: Boehringer Ingelheim Investigational Site
city: Lenesice
country: Czech Republic
facility: Boehringer Ingelheim Investigational Site
city: Letohrad
country: Czech Republic
facility: Boehringer Ingelheim Investigational Site
city: Liberec
country: Czech Republic
facility: Boehringer Ingelheim Investigational Site
city: Libesice
country: Czech Republic
facility: Boehringer Ingelheim Investigational Site
city: Libochovice
country: Czech Republic
facility: Boehringer Ingelheim Investigational Site
city: Lipová Lázne
country: Czech Republic
facility: Boehringer Ingelheim Investigational Site
city: Litomerice
country: Czech Republic
facility: Boehringer Ingelheim Investigational Site
city: Litovel
country: Czech Republic
facility: Boehringer Ingelheim Investigational Site
city: Litvínov
country: Czech Republic
facility: Boehringer Ingelheim Investigational Site
city: Lomnice n.P.
country: Czech Republic
facility: Boehringer Ingelheim Investigational Site
city: Louny
country: Czech Republic
facility: Boehringer Ingelheim Investigational Site
city: Lovosice
country: Czech Republic
facility: Boehringer Ingelheim Investigational Site
city: Ludgérovice
country: Czech Republic
facility: Boehringer Ingelheim Investigational Site
city: Mariánské Lázne
country: Czech Republic
facility: Boehringer Ingelheim Investigational Site
city: Melník
country: Czech Republic
facility: Boehringer Ingelheim Investigational Site
city: Mesto Albrechtice
country: Czech Republic
facility: Boehringer Ingelheim Investigational Site
city: Milovice
country: Czech Republic
facility: Boehringer Ingelheim Investigational Site
city: Milín
country: Czech Republic
facility: Boehringer Ingelheim Investigational Site
city: Mladá Boleslav
country: Czech Republic
facility: Boehringer Ingelheim Investigational Site
city: Mlázovice
country: Czech Republic
facility: Boehringer Ingelheim Investigational Site
city: Mnísek pod Brdy
country: Czech Republic
facility: Boehringer Ingelheim Investigational Site
city: Modrice
country: Czech Republic
facility: Boehringer Ingelheim Investigational Site
city: Mohelnice
country: Czech Republic
facility: Boehringer Ingelheim Investigational Site
city: Mor.Budejovice
country: Czech Republic
facility: Boehringer Ingelheim Investigational Site
city: Mor.Krumlov
country: Czech Republic
facility: Boehringer Ingelheim Investigational Site
city: Mor.Nová Ves
country: Czech Republic
facility: Boehringer Ingelheim Investigational Site
city: Moravany
country: Czech Republic
facility: Boehringer Ingelheim Investigational Site
city: Most
country: Czech Republic
facility: Boehringer Ingelheim Investigational Site
city: Míretice
country: Czech Republic
facility: Boehringer Ingelheim Investigational Site
city: Mýto
country: Czech Republic
facility: Boehringer Ingelheim Investigational Site
city: Nasavrky
country: Czech Republic
facility: Boehringer Ingelheim Investigational Site
city: Nechanice
country: Czech Republic
facility: Boehringer Ingelheim Investigational Site
city: Neratovice
country: Czech Republic
facility: Boehringer Ingelheim Investigational Site
city: Nová Ves pod Plesí
country: Czech Republic
facility: Boehringer Ingelheim Investigational Site
city: Nové Mesto nad Metují
country: Czech Republic
facility: Boehringer Ingelheim Investigational Site
city: Nový Bor
country: Czech Republic
facility: Boehringer Ingelheim Investigational Site
city: Nový Bydzov
country: Czech Republic
facility: Boehringer Ingelheim Investigational Site
city: Nový Jicín
country: Czech Republic
facility: Boehringer Ingelheim Investigational Site
city: Nový Knín
country: Czech Republic
facility: Boehringer Ingelheim Investigational Site
city: Nymburk
country: Czech Republic
facility: Boehringer Ingelheim Investigational Site
city: Náchod
country: Czech Republic
facility: Boehringer Ingelheim Investigational Site
city: Námest nad Oslavou
country: Czech Republic
facility: Boehringer Ingelheim Investigational Site
city: Obratan
country: Czech Republic
facility: Boehringer Ingelheim Investigational Site
city: Obríství
country: Czech Republic
facility: Boehringer Ingelheim Investigational Site
city: Olomouc
country: Czech Republic
facility: Boehringer Ingelheim Investigational Site
city: Opava
country: Czech Republic
facility: Boehringer Ingelheim Investigational Site
city: Opocno
country: Czech Republic
facility: Boehringer Ingelheim Investigational Site
city: Orlová
country: Czech Republic
facility: Boehringer Ingelheim Investigational Site
city: Ostrava
country: Czech Republic
facility: Boehringer Ingelheim Investigational Site
city: Otrokovice
country: Czech Republic
facility: Boehringer Ingelheim Investigational Site
city: Pacov
country: Czech Republic
facility: Boehringer Ingelheim Investigational Site
city: Pardubice
country: Czech Republic
facility: Boehringer Ingelheim Investigational Site
city: Pelhrimov
country: Czech Republic
facility: Boehringer Ingelheim Investigational Site
city: Petrvald
country: Czech Republic
facility: Boehringer Ingelheim Investigational Site
city: Pierov
country: Czech Republic
facility: Boehringer Ingelheim Investigational Site
city: Planá
country: Czech Republic
facility: Boehringer Ingelheim Investigational Site
city: Plzen
country: Czech Republic
facility: Boehringer Ingelheim Investigational Site
city: Polná
country: Czech Republic
facility: Boehringer Ingelheim Investigational Site
city: Postoloprty
country: Czech Republic
facility: Boehringer Ingelheim Investigational Site
city: Postrelmov
country: Czech Republic
facility: Boehringer Ingelheim Investigational Site
city: Prachatice
country: Czech Republic
facility: Boehringer Ingelheim Investigational Site
city: Praha
country: Czech Republic
facility: Boehringer Ingelheim Investigational Site
city: Prelouc
country: Czech Republic
facility: Boehringer Ingelheim Investigational Site
city: Prestice
country: Czech Republic
facility: Boehringer Ingelheim Investigational Site
city: Prostejov
country: Czech Republic
facility: Boehringer Ingelheim Investigational Site
city: Príbram
country: Czech Republic
facility: Boehringer Ingelheim Investigational Site
city: Písek
country: Czech Republic
facility: Boehringer Ingelheim Investigational Site
city: Radonice
country: Czech Republic
facility: Boehringer Ingelheim Investigational Site
city: Rakovník
country: Czech Republic
facility: Boehringer Ingelheim Investigational Site
city: Raspenava
country: Czech Republic
facility: Boehringer Ingelheim Investigational Site
city: Revnice
country: Czech Republic
facility: Boehringer Ingelheim Investigational Site
city: Rokycany
country: Czech Republic
facility: Boehringer Ingelheim Investigational Site
city: Roudnice nad Labem
country: Czech Republic
facility: Boehringer Ingelheim Investigational Site
city: Roznov pod Radhostem
country: Czech Republic
facility: Boehringer Ingelheim Investigational Site
city: Ruda nad Moravou
country: Czech Republic
facility: Boehringer Ingelheim Investigational Site
city: Rudná u Prahy
country: Czech Republic
facility: Boehringer Ingelheim Investigational Site
city: Rumburk
country: Czech Republic
facility: Boehringer Ingelheim Investigational Site
city: Rychnov nad Kneznou
country: Czech Republic
facility: Boehringer Ingelheim Investigational Site
city: Rícany u Brna
country: Czech Republic
facility: Boehringer Ingelheim Investigational Site
city: Rýmarov
country: Czech Republic
facility: Boehringer Ingelheim Investigational Site
city: Saratice
country: Czech Republic
facility: Boehringer Ingelheim Investigational Site
city: Semily
country: Czech Republic
facility: Boehringer Ingelheim Investigational Site
city: Senov u NJ
country: Czech Republic
facility: Boehringer Ingelheim Investigational Site
city: Skutec
country: Czech Republic
facility: Boehringer Ingelheim Investigational Site
city: Slaný
country: Czech Republic
facility: Boehringer Ingelheim Investigational Site
city: Slatinany
country: Czech Republic
facility: Boehringer Ingelheim Investigational Site
city: Slavicín
country: Czech Republic
facility: Boehringer Ingelheim Investigational Site
city: Slusovice
country: Czech Republic
facility: Boehringer Ingelheim Investigational Site
city: Smidary
country: Czech Republic
facility: Boehringer Ingelheim Investigational Site
city: Smirice
country: Czech Republic
facility: Boehringer Ingelheim Investigational Site
city: Sokolov
country: Czech Republic
facility: Boehringer Ingelheim Investigational Site
city: Spálené Porící
country: Czech Republic
facility: Boehringer Ingelheim Investigational Site
city: Staré Mesto
country: Czech Republic
facility: Boehringer Ingelheim Investigational Site
city: Starý Plzenec
country: Czech Republic
facility: Boehringer Ingelheim Investigational Site
city: Stenovice
country: Czech Republic
facility: Boehringer Ingelheim Investigational Site
city: Stetí
country: Czech Republic
facility: Boehringer Ingelheim Investigational Site
city: Strakonice
country: Czech Republic
facility: Boehringer Ingelheim Investigational Site
city: Stríbro
country: Czech Republic
facility: Boehringer Ingelheim Investigational Site
city: Studená
country: Czech Republic
facility: Boehringer Ingelheim Investigational Site
city: Studénka
country: Czech Republic
facility: Boehringer Ingelheim Investigational Site
city: Stáhlavy
country: Czech Republic
facility: Boehringer Ingelheim Investigational Site
city: Sumperk
country: Czech Republic
facility: Boehringer Ingelheim Investigational Site
city: Svetlá nad Sázavou
country: Czech Republic
facility: Boehringer Ingelheim Investigational Site
city: Teplice
country: Czech Republic
facility: Boehringer Ingelheim Investigational Site
city: Tisnov
country: Czech Republic
facility: Boehringer Ingelheim Investigational Site
city: Tlucná
country: Czech Republic
facility: Boehringer Ingelheim Investigational Site
city: Touzim
country: Czech Republic
facility: Boehringer Ingelheim Investigational Site
city: Trebíc
country: Czech Republic
facility: Boehringer Ingelheim Investigational Site
city: Tremosná
country: Czech Republic
facility: Boehringer Ingelheim Investigational Site
city: Trest
country: Czech Republic
facility: Boehringer Ingelheim Investigational Site
city: Trinec
country: Czech Republic
facility: Boehringer Ingelheim Investigational Site
city: Trutnov
country: Czech Republic
facility: Boehringer Ingelheim Investigational Site
city: Tupesy
country: Czech Republic
facility: Boehringer Ingelheim Investigational Site
city: Turnov
country: Czech Republic
facility: Boehringer Ingelheim Investigational Site
city: Tábor
country: Czech Republic
facility: Boehringer Ingelheim Investigational Site
city: Uherské Hradiste
country: Czech Republic
facility: Boehringer Ingelheim Investigational Site
city: Uherský Brod
country: Czech Republic
facility: Boehringer Ingelheim Investigational Site
city: Val.Bystrice
country: Czech Republic
facility: Boehringer Ingelheim Investigational Site
city: Valasské Mezirící
country: Czech Republic
facility: Boehringer Ingelheim Investigational Site
city: Vamberk
country: Czech Republic
facility: Boehringer Ingelheim Investigational Site
city: Varnsdorf
country: Czech Republic
facility: Boehringer Ingelheim Investigational Site
city: Velká Bítes
country: Czech Republic
facility: Boehringer Ingelheim Investigational Site
city: Velké Mezirící
country: Czech Republic
facility: Boehringer Ingelheim Investigational Site
city: Velké Opatovice
country: Czech Republic
facility: Boehringer Ingelheim Investigational Site
city: Velké Porící
country: Czech Republic
facility: Boehringer Ingelheim Investigational Site
city: Veselí nad Moravou
country: Czech Republic
facility: Boehringer Ingelheim Investigational Site
city: Vintírov
country: Czech Republic
facility: Boehringer Ingelheim Investigational Site
city: Vlasim
country: Czech Republic
facility: Boehringer Ingelheim Investigational Site
city: Vodnany
country: Czech Republic
facility: Boehringer Ingelheim Investigational Site
city: Votice
country: Czech Republic
facility: Boehringer Ingelheim Investigational Site
city: Vrbno pod Pradedem
country: Czech Republic
facility: Boehringer Ingelheim Investigational Site
city: Vsetín
country: Czech Republic
facility: Boehringer Ingelheim Investigational Site
city: Vyskov
country: Czech Republic
facility: Boehringer Ingelheim Investigational Site
city: Vysoké Mýto
country: Czech Republic
facility: Boehringer Ingelheim Investigational Site
city: Vápenná
country: Czech Republic
facility: Boehringer Ingelheim Investigational Site
city: Zamberk
country: Czech Republic
facility: Boehringer Ingelheim Investigational Site
city: Zastávka u Brna
country: Czech Republic
facility: Boehringer Ingelheim Investigational Site
city: Zatec
country: Czech Republic
facility: Boehringer Ingelheim Investigational Site
city: Zbýsov
country: Czech Republic
facility: Boehringer Ingelheim Investigational Site
city: Zdár nad Sázavou
country: Czech Republic
facility: Boehringer Ingelheim Investigational Site
city: Zinkovy
country: Czech Republic
facility: Boehringer Ingelheim Investigational Site
city: Zirovnice
country: Czech Republic
facility: Boehringer Ingelheim Investigational Site
city: Zlín
country: Czech Republic
facility: Boehringer Ingelheim Investigational Site
city: Znojmo
country: Czech Republic
facility: Boehringer Ingelheim Investigational Site
city: Zábieh
country: Czech Republic
facility: Boehringer Ingelheim Investigational Site
city: Ústek
country: Czech Republic
facility: Boehringer Ingelheim Investigational Site
city: Ústí nad Labem
country: Czech Republic
facility: Boehringer Ingelheim Investigational Site
city: Ústí nad Orlicí
country: Czech Republic
facility: Boehringer Ingelheim Investigational Site
city: Elva
country: Estonia
facility: Boehringer Ingelheim Investigational Site
city: Haapsalu
country: Estonia
facility: Boehringer Ingelheim Investigational Site
city: Johvi
country: Estonia
facility: Boehringer Ingelheim Investigational Site
city: Kohtla-Jarve
country: Estonia
facility: Boehringer Ingelheim Investigational Site
city: Kose
country: Estonia
facility: Boehringer Ingelheim Investigational Site
city: Laane-Virumaa
country: Estonia
facility: Boehringer Ingelheim Investigational Site
city: Narva
country: Estonia
facility: Boehringer Ingelheim Investigational Site
city: Paide
country: Estonia
facility: Boehringer Ingelheim Investigational Site
city: Parne
country: Estonia
facility: Boehringer Ingelheim Investigational Site
city: Polva
country: Estonia
facility: Boehringer Ingelheim Investigational Site
city: Rakvere
country: Estonia
facility: Boehringer Ingelheim Investigational Site
city: Sillamae
country: Estonia
facility: Boehringer Ingelheim Investigational Site
city: Tallinn
country: Estonia
facility: Boehringer Ingelheim Investigational Site
city: Tartu
country: Estonia
facility: Boehringer Ingelheim Investigational Site
city: Viljandi
country: Estonia
facility: Boehringer Ingelheim Investigational Site
city: Bryansk
country: Russian Federation
facility: Boehringer Ingelheim Investigational Site
city: Dmitrov
country: Russian Federation
facility: Boehringer Ingelheim Investigational Site
city: Dolgoprudnii
country: Russian Federation
facility: Boehringer Ingelheim Investigational Site
city: Dzerzinsk
country: Russian Federation
facility: Boehringer Ingelheim Investigational Site
city: Gukovscii
country: Russian Federation
facility: Boehringer Ingelheim Investigational Site
city: Ivanovo
country: Russian Federation
facility: Boehringer Ingelheim Investigational Site
city: Moscow
country: Russian Federation
facility: Boehringer Ingelheim Investigational Site
city: Nijnii Novgorod
country: Russian Federation
facility: Boehringer Ingelheim Investigational Site
city: Nizhni Novgorod
country: Russian Federation
facility: Boehringer Ingelheim Investigational Site
city: Podolsk
country: Russian Federation
facility: Boehringer Ingelheim Investigational Site
city: Ryazan
country: Russian Federation
facility: Boehringer Ingelheim Investigational Site
city: Smolensk
country: Russian Federation
facility: Boehringer Ingelheim Investigational Site
city: Vladimir
country: Russian Federation
facility: Boehringer Ingelheim Investigational Site
city: Yaroslavl
country: Russian Federation
facility: Boehringer Ingelheim Investigational Site
city: Bardejov
country: Slovakia
facility: Boehringer Ingelheim Investigational Site
city: Bosany
country: Slovakia
facility: Boehringer Ingelheim Investigational Site
city: Bran?
country: Slovakia
facility: Boehringer Ingelheim Investigational Site
city: Bánovce/Bebravou
country: Slovakia
facility: Boehringer Ingelheim Investigational Site
city: Handlová
country: Slovakia
facility: Boehringer Ingelheim Investigational Site
city: Humenné
country: Slovakia
facility: Boehringer Ingelheim Investigational Site
city: Kezmarok
country: Slovakia
facility: Boehringer Ingelheim Investigational Site
city: Kluknava
country: Slovakia
facility: Boehringer Ingelheim Investigational Site
city: Kosice
country: Slovakia
facility: Boehringer Ingelheim Investigational Site
city: Krompachy
country: Slovakia
facility: Boehringer Ingelheim Investigational Site
city: Liptovský Mikulás
country: Slovakia
facility: Boehringer Ingelheim Investigational Site
city: Malacky
country: Slovakia
facility: Boehringer Ingelheim Investigational Site
city: Martin
country: Slovakia
facility: Boehringer Ingelheim Investigational Site
city: Michalovce
country: Slovakia
facility: Boehringer Ingelheim Investigational Site
city: Nitra
country: Slovakia
facility: Boehringer Ingelheim Investigational Site
city: Nove Mesto/Váhom
country: Slovakia
facility: Boehringer Ingelheim Investigational Site
city: Námestovo
country: Slovakia
facility: Boehringer Ingelheim Investigational Site
city: Pies?any
country: Slovakia
facility: Boehringer Ingelheim Investigational Site
city: Poprad
country: Slovakia
facility: Boehringer Ingelheim Investigational Site
city: Presov
country: Slovakia
facility: Boehringer Ingelheim Investigational Site
city: Ruzomberok
country: Slovakia
facility: Boehringer Ingelheim Investigational Site
city: Se?ovská Polianka
country: Slovakia
facility: Boehringer Ingelheim Investigational Site
city: Senec
country: Slovakia
facility: Boehringer Ingelheim Investigational Site
city: Spisská Nová Ves
country: Slovakia
facility: Boehringer Ingelheim Investigational Site
city: St. ?ubov?a
country: Slovakia
facility: Boehringer Ingelheim Investigational Site
city: Stará Turá
country: Slovakia
facility: Boehringer Ingelheim Investigational Site
city: Stropkov
country: Slovakia
facility: Boehringer Ingelheim Investigational Site
city: Svinia
country: Slovakia
facility: Boehringer Ingelheim Investigational Site
city: Topo??any
country: Slovakia
facility: Boehringer Ingelheim Investigational Site
city: Torna?a
country: Slovakia
facility: Boehringer Ingelheim Investigational Site
city: Trebisov
country: Slovakia
facility: Boehringer Ingelheim Investigational Site
city: Tren?ín
country: Slovakia
facility: Boehringer Ingelheim Investigational Site
city: Trhoviste
country: Slovakia
facility: Boehringer Ingelheim Investigational Site
city: Vranov/Top?ou
country: Slovakia
facility: Boehringer Ingelheim Investigational Site
city: Vrútky
country: Slovakia
facility: Boehringer Ingelheim Investigational Site
city: Zilina
country: Slovakia
facility: Boehringer Ingelheim Investigational Site
Study officials:
affiliation: Boehringer Ingelheim
name: Boehringer Ingelheim
role: STUDY_CHAIR
References: